SU-F-J-179: Commissioning Dosimetric Data of a New 2.5 Megavoltage Imaging Beam from a TrueBeam Linear

2016 ◽  
Vol 43 (6Part11) ◽  
pp. 3449-3449
Author(s):  
G Ding
Keyword(s):  
Dosimetric Data ◽  
Megavoltage Imaging ◽  
Imaging Beam

SU-C-214-01: Design and Evaluation of a Low Megavoltage Imaging Beam from a Prototype Waveguide

2011 ◽  
Vol 38 (6Part2) ◽  
pp. 3372-3372
Author(s):  
D Roberts ◽  
V Hansen ◽  
A Niven ◽  
G Poludniowski ◽  
J Seco ◽  
...  
Keyword(s):  
Megavoltage Imaging ◽  
Imaging Beam

scholarly journals 455 Proton Beam Therapy in Rectal Cancer: A Systematic Review and Meta-Analysis

2021 ◽  
Vol 108 (Supplement_2) ◽  
Author(s):  
M Fok ◽  
S Toh ◽  
J E Maducolil ◽  
H Fowler ◽  
R Clifford ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Proton Beam ◽  
Organs At Risk ◽  
Meta Analysis ◽  
Locally Advanced ◽  
Significant Risk ◽  
Proton Beam Therapy ◽  
Recurrent Rectal Cancer ◽  
Pelvic Bone ◽  
Dosimetric Data

Abstract Introduction Radiotherapy for locally advanced rectal cancer is conventionally performed using photon-based radiotherapy (PBR), carrying significant risk of toxicity to organs at risk (OAR). Proton beam therapy (PBT) potentially delivers equivalent dosimetric radiation to the targeted tissue with improved sparing of OAR. We aimed to compare dosimetric irradiation of OAR for PBT versus PBR in patients with rectal cancer and assess any oncological outcomes. Method An extensive electronic literature search was performed from inception till April 2020 and subsequent meta-analysis performed. Results Six articles met the inclusion criteria. Dosimetric data of irradiation delivered to OAR for PBT and PBR were calculated for the same patients. PBT had significantly less irradiated small bowel compared to 3DCRT and IMRT, (MD -16.95, 95% CI [-24.03, -9.88], p < 0.00001) and (MD -6.96, 95% CI [-12.99, -0.94], p = 0.02) respectively. Similar results were observed for bladder and pelvic bone marrow. Two studies reported clinical and oncological results for PBT in recurrent rectal cancer with overall survival reported as 43% and 68%. Conclusions Dosimetric treatment plans have less irradiation of OAR for rectal cancer with PBT compared to PBR. There is a need for further research in PBT and rectal cancer, as promising results have been shown in recurrent rectal cancer.

scholarly journals Hybrid volumetric-modulated arc therapy for postoperative breast cancer including regional lymph nodes: the advantage of dosimetric data and safety of toxicities

2020 ◽  
Vol 61 (5) ◽  
pp. 747-754
Author(s):  
Yoshiko Doi ◽  
Minoru Nakao ◽  
Hideharu Miura ◽  
Shuichi Ozawa ◽  
Masahiro Kenjo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Nodes ◽  
Irradiation Dose ◽  
Organs At Risk ◽  
Volumetric Modulated Arc Therapy ◽  
Conformity Index ◽  
Regional Lymph Nodes ◽  
Dosimetric Data ◽  
Arc Therapy

ABSTRACT To improve the homogeneity and conformity of the irradiation dose for postoperative breast cancer including regional lymph nodes, we planned Hybrid volumetric-modulated arc therapy (VMAT), which combines conventional tangential field mainly for the chest area and VMAT mainly for the supraclavicular area and marginal zone. In this study, we compared the dosimetric impact between traditional 3D conformal radiotherapy (3DCRT) and Hybrid VMAT and observed toxicities following Hybrid VMAT. A total of 70 patients indicated between October 2016 and December 2017 were included. The prescribed dose was 50 Gy/25 fractions. For the dosimetric impact, 3DCRT and Hybrid VMAT plans were compared in each patient with respect to the dosimetric parameters. Toxicities were followed using the Common Terminology Criteria for Adverse Events version 4.0. The median follow-up duration was 319 days. For the dosimetric impact, the homogeneity index (HI) and conformity index (CI) of PTV were significantly improved in the Hybrid VMAT plan compared with that in the 3DCRT plan (HI, 0.15 ± 0.07 in Hybrid VMAT vs 0.41 ± 0.19 in 3DCRT, P < 0.001; CI, 1.61 ± 0.44 in Hybrid VMAT vs 2.10 ± 0.56 in 3DCRT, P < 0.001). The mean irradiated ipsilateral lung dose was not significantly different in both plans (12.0 ± 2.4 Gy in Hybrid VMAT vs 11.8 ± 2.8 Gy in 3DCRT, P < 0.533). Regarding toxicity, there were no patients who developed ≥grade 3 acute toxicity and ≥grade 2 pneumonitis during the follow-up. Hybrid VMAT for postoperative breast cancer including regional lymph nodes was a reasonable technique that improved the homogeneity and conformity of the irradiation dose to the planning target volume while keeping the irradiation dose to organs at risk to a minimum.

Feasibility study of a dual detector configuration concept for simultaneous megavoltage imaging and dose verification in radiotherapy

2015 ◽  
Vol 42 (4) ◽  
pp. 1753-1764 ◽  
Author(s):  
Shrikant Deshpande ◽  
Aimee L. McNamara ◽  
Lois Holloway ◽  
Peter Metcalfe ◽  
Philip Vial
Keyword(s):  
Feasibility Study ◽  
Dose Verification ◽  
Megavoltage Imaging ◽  
Dual Detector

Dosimetric data

2018 ◽  
pp. 33-45
Author(s):  
Issam El Naqa ◽  
Randall K. Ten Haken
Keyword(s):  
Dosimetric Data
Sign in / Sign up

Export Citation Format

Share Document